Value through Innovation27 July 2016

Clinical Study Results

  • YENTREVE ® - Depressive Disorder, Major
    Clinical Study Number 1208.24
    Study Indication Depressive Disorder, Major
    Product YENTREVE ®
    Generic Name Duloxetine
    Lab Code
    Clinical Phase IV
    Study Title

    An eight-week, randomized, double-blind, two parallel groups, study to assess clinical response of duloxetine 60 mg and 120 mg per day in patients hospitalized for severe depression.

    Study Document Trial synopsis 1208.24_DR english
  • YENTREVE ® - Depressive Disorder, Major
    Clinical Study Number 1208.10
    Study Indication Depressive Disorder, Major
    Product YENTREVE ®
    Generic Name Duloxetine
    Lab Code
    Clinical Phase IIIb
    Study Title

    A ten-week, randomized, double-blind study evaluating the efficacy of duloxetine 60 mg once daily versus placebo in outpatients with major depressive disorder and pain (EU-Pain enriched study)

    Study Document Trial synopsis 1208.10 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.